Envestnet Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $651K | Sell |
69,411
-3,739
| -5% | -$35.1K | ﹤0.01% | 3518 |
|
|
2025
Q1 | $520K | Buy |
73,150
+6,496
| +10% | +$46.2K | ﹤0.01% | 3597 |
|
|
2024
Q4 | $777K | Sell |
66,654
-13,323
| -17% | -$155K | ﹤0.01% | 3329 |
|
|
2024
Q3 | $1.64M | Buy |
79,977
+24,421
| +44% | +$502K | ﹤0.01% | 2798 |
|
|
2024
Q2 | $1.24M | Buy |
55,556
+4,264
| +8% | +$95.4K | ﹤0.01% | 2885 |
|
|
2024
Q1 | $1.41M | Buy |
51,292
+2,036
| +4% | +$56K | ﹤0.01% | 2797 |
|
|
2023
Q4 | $1.5M | Buy |
49,256
+12,499
| +34% | +$381K | ﹤0.01% | 2644 |
|
|
2023
Q3 | $1.16M | Buy |
36,757
+17,500
| +91% | +$553K | ﹤0.01% | 2698 |
|
|
2023
Q2 | $785K | Sell |
19,257
-244
| -1% | -$9.95K | ﹤0.01% | 2930 |
|
|
2023
Q1 | $727K | Buy |
19,501
+967
| +5% | +$36K | ﹤0.01% | 2900 |
|
|
2022
Q4 | $647K | Sell |
18,534
-2,420
| -12% | -$84.4K | ﹤0.01% | 2945 |
|
|
2022
Q3 | $1.17M | Sell |
20,954
-366
| -2% | -$20.5K | ﹤0.01% | 2438 |
|
|
2022
Q2 | $1.1M | Sell |
21,320
-236
| -1% | -$12.2K | ﹤0.01% | 2509 |
|
|
2022
Q1 | $1.57M | Sell |
21,556
-3,676
| -15% | -$267K | ﹤0.01% | 2355 |
|
|
2021
Q4 | $2.98M | Buy |
25,232
+3,181
| +14% | +$376K | ﹤0.01% | 1909 |
|
|
2021
Q3 | $2.96M | Buy |
22,051
+769
| +4% | +$103K | ﹤0.01% | 1848 |
|
|
2021
Q2 | $3.45M | Sell |
21,282
-1,359
| -6% | -$220K | ﹤0.01% | 1732 |
|
|
2021
Q1 | $1.82M | Buy |
22,641
+7,213
| +47% | +$579K | ﹤0.01% | 1999 |
|
|
2020
Q4 | $839K | Buy |
+15,428
| New | +$839K | ﹤0.01% | 2338 |
|